Primer: inflammasomes and interleukin 1beta in inflammatory disorders (Q28263370)

Nature Clinical Practice Rheumatology

Europe PubMed Central

title

Primer: inflammasomes and interleukin 1beta in inflammatory disorders (English)

0 references

0 references

0 references

1 reference

3

Michael F McDermott

0 references

Graham P. Cook

object named as

Graham P Cook

series ordinal

2

0 references

author name string

Leigh D Church

series ordinal

1

0 references

language of work or name

English

0 references

publication date

January 2008

0 references

published in

0 references

volume

4

0 references

issue

1

0 references

page(s)

34-42

0 references

cites work

NLRs join TLRs as innate sensors of pathogens

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Gout-associated uric acid crystals activate the NALP3 inflammasome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Hereditary auto-inflammatory disorders and biologics

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

How Toll-like receptors signal: what we know and what we don't know

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Molecular identification of a danger signal that alerts the immune system to dying cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

CATERPILLERs, pyrin and hereditary immunological disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Nod-like proteins in immunity, inflammation and disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

CARD15 mutations in Blau syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A new CARD15 mutation in Blau syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Interleukin-18: a novel cytokine that augments both innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Cryopyrin-induced interleukin 1beta secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Inflammatory caspases and inflammasomes: master switches of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Cryopyrin activates the inflammasome in response to toxins and ATP

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Cutting edge: CIAS1/cryopyrin/PYPAF1/NALP3/CATERPILLER 1.1 is an inducible inflammatory mediator with NF-kappa B suppressive properties

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Activation of the IL-1β-Processing Inflammasome Is Involved in Contact Hypersensitivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Cloning IL-1 and the birth of a new era in cytokine biology

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Mutations in cryopyrin: bypassing roadblocks in the caspase 1 inflammasome for interleukin-1beta secretion and disease activity

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

ICEBERG: a novel inhibitor of interleukin-1beta generation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Pyrin-only protein 2 modulates NF-kappaB and disrupts ASC:CLR interactions

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Blocking IL-1 in systemic inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Hereditary periodic fever syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A common pathway in periodic fever syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A pilot study of IL-1 inhibition by anakinra in acute gout

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A proposed classification of the immunological diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Still's disease in the adult

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Rapid responses to anakinra in patients with refractory adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

A pilot trial of external Qigong therapy for arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Gene transfer to human joints: progress toward a gene therapy of arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021

Reactivation of pulmonary tuberculosis in a patient with rheumatoid arthritis during treatment with IL-1 receptor antagonists (anakinra)

1 reference

https://api.crossref.org/works/10.1038%2FNCPRHEUM0681

7 January 2021